Skip to main content
Top
Gepubliceerd in: Tijdschrift voor Kindergeneeskunde 5/2010

01-10-2010

GAMT-deficiëntie: een behandelbare stoornis in de creatinestofwisseling

Auteurs: Dhr. Barend J. G. Dam, dhr. drs. Floris C. Hofstede, dhr. dr. Berthil H. C. M. T. Prinsen, Mw. dr. Gajja S. Salomons, Dr. G. Visser

Gepubliceerd in: Tijdschrift voor Kindergeneeskunde | Uitgave 5/2010

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Samenvatting

Deficiëntie van guanidinoacetaatmethyltransferase (GAMT) is een relatief recent ontdekte aangeboren stofwisselingsziekte in de creatinestofwisseling. Patiënten presenteren zich met achterstand in ontwikkeling, epilepsie en/of een bewegingsstoornis. Onderzoek naar de ziekte is eenvoudig uit te voeren door metabool onderzoek in plasma en urine in een laboratorium dat gespecialiseerd is in metabole ziekten.Wanneer behandeling uitblijft, leidt de ziekte tot progressieve hersenschade, terwijl dit met vroegtijdige behandeling voorkomen kan worden. Aan de hand van de ziektegeschiedenis van een patiënt wordt ingegaan op de klinische symptomen, diagnostiek en behandeling van deze ziekte
Literatuur
1.
go back to reference Stöckler-Ipsiroglu S, Schutz PW, Salomons GS. Cerebral creatine deficiency syndromes: clinical aspects, treatment and pathophysiology. Subcell Biochem. 2007;46:149–66.CrossRef Stöckler-Ipsiroglu S, Schutz PW, Salomons GS. Cerebral creatine deficiency syndromes: clinical aspects, treatment and pathophysiology. Subcell Biochem. 2007;46:149–66.CrossRef
2.
go back to reference Stöckler S, Holzbach U, Hanefeld F, et al. Creatine deficiency in the brain: a new, treatable inborn error of metabolism. Pediatr Res. 1994;36:409–13.PubMedCrossRef Stöckler S, Holzbach U, Hanefeld F, et al. Creatine deficiency in the brain: a new, treatable inborn error of metabolism. Pediatr Res. 1994;36:409–13.PubMedCrossRef
3.
go back to reference Wyss M, Kaddurah-Daouk R. Creatine and creatinine metabolism. Physiol Rev. 2000;80:1107–213.PubMed Wyss M, Kaddurah-Daouk R. Creatine and creatinine metabolism. Physiol Rev. 2000;80:1107–213.PubMed
4.
go back to reference Stromberger C, Bodamer OA, Stöckler- Ipsiroglu S. Clinical characteristics and diagnostic clues in inborn errors of creatine metabolism. J Inherit Metab Dis. 2003;26:299–308.PubMedCrossRef Stromberger C, Bodamer OA, Stöckler- Ipsiroglu S. Clinical characteristics and diagnostic clues in inborn errors of creatine metabolism. J Inherit Metab Dis. 2003;26:299–308.PubMedCrossRef
5.
go back to reference Stöckler-Ipsiroglu S, Salomons GS. In: Fernandes J, Saudubray JM, Berghe van den G, en Walter JH. Inborn metabolic diseases, 4td ed. Springer, 2006. Hoofdstuk 16: 211–17. Stöckler-Ipsiroglu S, Salomons GS. In: Fernandes J, Saudubray JM, Berghe van den G, en Walter JH. Inborn metabolic diseases, 4td ed. Springer, 2006. Hoofdstuk 16: 211–17.
6.
go back to reference Schulze A, Hoffmann GF, Bachert P, et al. Presymptomatic treatment of neonatal guanidinoacetate methyltransferase deficiency. Neurology. 2006;67:719–21.PubMedCrossRef Schulze A, Hoffmann GF, Bachert P, et al. Presymptomatic treatment of neonatal guanidinoacetate methyltransferase deficiency. Neurology. 2006;67:719–21.PubMedCrossRef
7.
go back to reference Verbruggen KT, Sijens PE, Schulze A, et al. Successful treatment of a guanidinoacetate methyltransferase deficient patient: findings with relevance to treatment strategy and pathophysiology. Mol Genet Metab. 2007;91:294–6.PubMedCrossRef Verbruggen KT, Sijens PE, Schulze A, et al. Successful treatment of a guanidinoacetate methyltransferase deficient patient: findings with relevance to treatment strategy and pathophysiology. Mol Genet Metab. 2007;91:294–6.PubMedCrossRef
8.
go back to reference Almeida LS, Verhoeven NM, Roos B, et al. Creatine and guanidinoacetate: diagnostic markers for inborn errors in creatine biosynthesis and transport. Mol Genet Metab. 2004;82:214–9.PubMedCrossRef Almeida LS, Verhoeven NM, Roos B, et al. Creatine and guanidinoacetate: diagnostic markers for inborn errors in creatine biosynthesis and transport. Mol Genet Metab. 2004;82:214–9.PubMedCrossRef
9.
go back to reference Carling RS, Hogg SL,Wood TC, et al. Simultaneous determination of guanidinoacetate, creatine and creatinine in urine and plasma by underivatized liquid chromatographytandem mass spectrometry. Ann Clin Biochem. 2008;45(Pt 6):575–84.PubMedCrossRef Carling RS, Hogg SL,Wood TC, et al. Simultaneous determination of guanidinoacetate, creatine and creatinine in urine and plasma by underivatized liquid chromatographytandem mass spectrometry. Ann Clin Biochem. 2008;45(Pt 6):575–84.PubMedCrossRef
10.
go back to reference Carducci C, Birarelli M, Leuzzi V, et al. Guanidinoacetate and creatine plus creatinine assessment in physiologic fluids: an effective diagnostic tool for the biochemical diagnosis of arginine:glycine amidinotransferase and guanidinoacetate methyltransferase deficiencies. Clin Chem. 2002;48:1772–8.PubMed Carducci C, Birarelli M, Leuzzi V, et al. Guanidinoacetate and creatine plus creatinine assessment in physiologic fluids: an effective diagnostic tool for the biochemical diagnosis of arginine:glycine amidinotransferase and guanidinoacetate methyltransferase deficiencies. Clin Chem. 2002;48:1772–8.PubMed
11.
go back to reference Bianchi MC, Tosetti M, Battini R, et al. Treatment monitoring of brain creatine deficiency syndromes: a 1Hand 31P-MR spectroscopy study. AJNR Am J Neuroradiol. 2007;28: 548–54.PubMed Bianchi MC, Tosetti M, Battini R, et al. Treatment monitoring of brain creatine deficiency syndromes: a 1Hand 31P-MR spectroscopy study. AJNR Am J Neuroradiol. 2007;28: 548–54.PubMed
12.
go back to reference Dhar SU, Scaglia F, Li FY, et al. Expanded clinical and molecular spectrum of guanidinoacetate methyltransferase (GAMT) deficiency. Mol Genet Metab. 2009;96:38–43.PubMedCrossRef Dhar SU, Scaglia F, Li FY, et al. Expanded clinical and molecular spectrum of guanidinoacetate methyltransferase (GAMT) deficiency. Mol Genet Metab. 2009;96:38–43.PubMedCrossRef
13.
go back to reference Schulze A, Battini R. Pre-symptomatic treatment of creatine biosynthesis defects. Subcell Biochem. 2007;46: 167–81.PubMedCrossRef Schulze A, Battini R. Pre-symptomatic treatment of creatine biosynthesis defects. Subcell Biochem. 2007;46: 167–81.PubMedCrossRef
14.
go back to reference Schulze A, Bachert P, Schlemmer H, et al, Lack of creatine in muscle and brain in an adult with GAMT deficiency. Ann Neurol. 2003;53:248–51.PubMedCrossRef Schulze A, Bachert P, Schlemmer H, et al, Lack of creatine in muscle and brain in an adult with GAMT deficiency. Ann Neurol. 2003;53:248–51.PubMedCrossRef
15.
go back to reference Carducci C, Santagata S, Leuzzi V, et al. Quantitative determination of guanidinoacetate and creatine in dried blood spot by flow injection analysis-electrospray tandem mass spectrometry. Clin Chim Acta. 2006;364:180–7.PubMedCrossRef Carducci C, Santagata S, Leuzzi V, et al. Quantitative determination of guanidinoacetate and creatine in dried blood spot by flow injection analysis-electrospray tandem mass spectrometry. Clin Chim Acta. 2006;364:180–7.PubMedCrossRef
Metagegevens
Titel
GAMT-deficiëntie: een behandelbare stoornis in de creatinestofwisseling
Auteurs
Dhr. Barend J. G. Dam
dhr. drs. Floris C. Hofstede
dhr. dr. Berthil H. C. M. T. Prinsen
Mw. dr. Gajja S. Salomons
Dr. G. Visser
Publicatiedatum
01-10-2010
Uitgeverij
Bohn Stafleu van Loghum
Gepubliceerd in
Tijdschrift voor Kindergeneeskunde / Uitgave 5/2010
Print ISSN: 0376-7442
Elektronisch ISSN: 1875-6840
DOI
https://doi.org/10.1007/s12456-010-0052-x

Andere artikelen Uitgave 5/2010

Tijdschrift voor Kindergeneeskunde 5/2010 Naar de uitgave